Skip to main content
Pharmanutra logo

Pharmanutra — Investor Relations & Filings

Ticker · PHN ISIN · IT0005274094 LEI · 815600F8217BC7733697 XMIL Manufacturing
Open in API
Filings indexed 601 across all filing types
Latest filing 2022-05-12 Report Publication Anno…
Country IT Italy
Listing XMIL PHN

About Pharmanutra

http://www.pharmanutra.it

PharmaNutra is a company operating in the pharmaceutical and nutraceutical sectors, focused on the development and distribution of nutritional supplements and medical devices. Grounded in scientific research, the company creates innovative solutions for health and wellness. Its core activities center on addressing nutritional deficiencies, particularly iron, through proprietary functional ingredients and technologies. The product portfolio also extends to supporting muscle and joint health, sports nutrition, and applications across various therapeutic areas, including gynecology, orthopedics, hematology, and gastroenterology. The company emphasizes the development of effective and safe products supported by clinical evidence.

Recent filings

Filing Released Lang Actions
PR - PHN Interim financial report as of 31 March 2022
Report Publication Announcement Classification · 1% confidence The document is a regulatory announcement (indicated by 'Informazione Regolamentata' and 'REGEM' type) dated May 12, 2022. The subject line is 'PR - PHN Interim financial report as of 31 March 2022' and the headline states: '# **PHARMANUTRA S.P.A.: INTERIM FINANCIAL REPORT AS OF 31 MARCH 2022 NOW AVAILABLE**'. The text explicitly states that the 'Interim Financial Report as of 31st March 2022... is available at the Company's registered office... and on the authorized storage mechanism'. Since the document itself is an announcement about the availability of the report, and not the comprehensive report content, it fits the definition of a Report Publication Announcement (RPA). The document length (3881 chars) is short, supporting the 'MENU VS MEAL' rule.
2022-05-12 English
PR PHARMANUTRA - Approval of interim report as of 31 march 2022
Earnings Release Classification · 1% confidence The document is a press release from PharmaNutra S.p.A. announcing the approval of its interim financial results for the period ending March 31, 2022. While it contains substantive financial data (income statement, balance sheet, and analysis), it is structured as a corporate press release (Earnings Release) rather than a full statutory interim report. According to the filing definitions, an Earnings Release (ER) is the initial announcement of quarterly/periodical financial results containing key highlights, which matches this document's content and purpose. Q1 2022
2022-05-09 English
CS PHARMANUTRA - Approvazione resoconto intermedio di gestione al 31 marzo 2022
Interim / Quarterly Report Classification · 1% confidence The document is a press release from PharmaNutra S.p.A. announcing the approval of its interim management report for the period ending March 31, 2022. It contains key financial highlights, management commentary, and detailed financial tables (balance sheet, income statement). While it references an 'attached' report, the document itself provides substantive financial data and analysis for the quarter, qualifying it as an Interim/Quarterly Report (IR) rather than a mere publication announcement. Q1 2022
2022-05-09 Italian
PHN_Rendiconto votazioni_assemblea azionisti 27042022
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is titled "ASSEMBLEA ORDINARIA DEL 27 APRILE 2022" (Ordinary General Meeting of April 27, 2022) and provides a "Rendiconto sintetico delle votazioni sui punti all'ordine del giorno" (Summary report of the votes on the agenda items). It details the voting results for various resolutions, such as the approval of the 2021 financial statements, remuneration policy, appointment of the Board of Statutory Auditors, and authorization for share buybacks. This content directly relates to the proceedings and outcomes of an Annual General Meeting (AGM). Therefore, the appropriate classification is AGM Information (AGM-R).
2022-05-02 Italian
PHARMANUTRA_PR Synthetic report on voting results
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is an official notification from PHARMANUTRA S.P.A. dated May 2, 2022, regarding the 'SYNTHETIC REPORT ON VOTING RESULTS ON AGENDA ITEMS OF THE ORDINARY SHAREHOLDERS' MEETINGS HELD ON APRIL 27, 2022'. The subject line explicitly mentions 'voting results'. This directly corresponds to the definition of 'Declaration of Voting Results & Voting Rights Announcements' (DVA). Although the document states 'Vedi allegato' (See attachment) and points to where the full report is available, the core content being disseminated is the result of a shareholder vote, making DVA the most specific classification. It is not a general regulatory filing (RNS) because a more specific category exists.
2022-05-02 English
PHARMANUTRA - CS Rendiconto sintetico delle votazioni
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is an official communication (Informazione Regolamentata) from PHARMANUTRA dated May 2, 2022. The subject ('Oggetto') explicitly states 'delle votazioni' (of the votes) and the title confirms it is the 'RENDICONTO SINTETICO DELLE VOTAZIONI SUI PUNTI ALL'ORDINE DEL GIORNO DELL'ASSEMBLEA ORDINARIA' (Summary Report of the Votes on the Agenda Items of the Ordinary General Meeting). This directly corresponds to the definition of Declaration of Voting Results & Voting Rights Announcements (DVA). Although it mentions the report is available on the website ('Vedi allegato' and 'è disponibile sul sito internet'), the core content provided is the summary of the voting results itself, making DVA a more specific classification than RPA or RNS, especially since the document title focuses entirely on the voting results.
2022-05-02 Italian

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.